Video: Pegcetacoplan Data Show Increasing Benefit Over 5 Years

At the 2026 Macula Society meeting, Dilsher S. Dhoot, MD, discussed GALE extension results demonstrating progressive tissue preservation in geographic atrophy.

By: Dilsher S. Dhoot, MD

Retinal Physician March 7, 2026

-0:00/0:00

Dilsher S. Dhoot

Affiliations: California Retina Consultants

Specialties: Ophthalmology

Bio: Dilsher S. Dhoot, MD, is affiliated with California Retina Consultants. His clinical and academic work focuses on retinal disease, including geographic atrophy secondary to age-related macular degeneration. At the 2026 Macula Society meeting, Dr. Dhoot presented 5-year data on pegcetacoplan treatment for geographic atrophy, discussing results from the OAKS and DERBY phase 3 trials and the GALE open-label extension, including long-term tissue preservation and safety outcomes through 60 months.

PentaVision

Retinal Physician

Video: Pegcetacoplan Data Show Increasing Benefit Over 5 Years

Recommendations